Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice

Digestive Diseases and Sciences

Volumn 49, Issue 7-8, 2004, Pages 1095-1102

  Johnson Henry, Kathene Candace ^a   Mitchell, David J ^a   Avitzur, Yaron ^a   Galindo Mata, Esther ^a   Jones, Nicola L ^a   Sherman, Philip M ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

apoptosis; colonization; gastritis; Helicobacter pylori; probiotics

Indexed keywords

AGAR; COLISTIN; DRINKING WATER; LACIDOFIL; NALIDIXIC ACID; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; APOPTOSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BODY WEIGHT; BODY WEIGHT DISORDER; COLON; CONTROLLED STUDY; DIARRHEA; DILUTION; DISEASE SEVERITY; DRUG SAFETY; EPITHELIUM CELL; EXCRETION; EXPERIMENTAL INFECTION; FECES; FEEDING; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; ILEUM; INCUBATION TIME; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RECTUM PROLAPSE; SAMPLE; SENSITIVITY ANALYSIS; STOMACH ANTRUM; STOMACH EPITHELIUM; STOMACH MUCOSA; TISSUE HOMOGENATE; WEIGHT REDUCTION; WELLBEING;

ANIMALS; APOPTOSIS; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IN SITU NICK-END LABELING; LACTOBACILLUS; MICE; MICE, INBRED C57BL; PROBIOTICS;

EID: 4444308029     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000037794.02040.c2     Document Type: Article

References (44)

1. Metchnikoff E: The prolongation of life: optimistic studies. In C Mitchell (ed). Prolongation of Life. London, William Heinemann, 1907, pp 161-183
2. Guarner F, Malagelada JR: Gut flora in health and disease. Lancet 361(9356):512-519, 2003
3. Prajapati JB, Nair BM: The history of fermented foods. In Handbook of Fermented Foods. ER Farnworth (ed). Boca Raton, FL, CRC Press, 2003, pp 1-25
4. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, et al.: Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo controlled trial. Gastroenterology 124:1202-1209, 2003
5. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J: Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 73 (Suppl2):430S-436S, 2001
6. Huang, JS, Athos B; Lee JW, Diaz A, Davidson EJ: Efficacy of probiotic use in acute diarrhea in children: A meta-analysis. Dig Dis Sci 47(11):2625-2634, 2002
7. Van Neil CW, Feudtner C, Garrison MM, Christakis DA: Lactobacillus therapy for acute infectious diarrheain children: A meta-analysis. Pediatrics 109:678-684, 2002
8. Suerbaum S, Michetti P: Helicobacter pylori infection. N Engl J Med 347:1175-1186, 2002
9. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272:65, 1994
10. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Masson A, et al.: Helicobacter pylori, a paradigm for chronic mucosal inflammation and prevention. Adv Intern Med 41:85-117, 1996
11. Chatterjee A, Yasmin T, Bagchi D, Stohs S: The bactericidal effects of Lactobacillus acidophilus, garcinol and Protykin® compared to clarithromycin, on Helicobacter pylori. Mol Cell Biol 243:29-35, 2003
12. Johnson-Henry K, Tompkins T, Sherman P: Effect of lactobacillus on enterohemorrhagic Esherichia coli-induced alterations in intestinal epithelial cell permeability. Annu Meet Am Soc Microbiol, Orlando, FL, 2001, abstr B-188
13. Lee A, O'Rourke J, Ungaria MC, Robertson B, Daskalopoulos G, Dixon MF: A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain. Gastroenterology 112:1386-1397, 1997
14. Jones N, Day A, Jennings HA, Sherman PM: Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun 67:4237-4242, 1999
15. Schillinger U, Lucke FK: Antibacterial activity of Lactobacillus sake isolated from meat. Appl Environ Microbiol 55(8):1901-1906, 1989
16. Cantey J, Hosterman D: Characterization of colonization of the rabbit gastrointestinal tract by Escherichia coli RDEC-1. Infect Immun 26(3):1099-1103, 1979
17. Jones N, Day A, Jennings HA, Shannon PT, Galindo-Mata E, Sherman PM: Enhanced disease severity in Helicobacter pylori-infected mice deficient in Fas signaling. Infect Immun 70(5):2591-2597, 2002
18. P. Sutton, Wilson J, Lee A: Further development of the Helicobacter pylori mouse vaccination model. Vaccine 18:2677-2685, 2000
19. Drumm B, Sherman P, Cutz E, Karmali M: Association of Campylobacterpylori on the gastric mucosa with antral gastritis in children. N Engl J Med 316:1557-1561, 1987
20. Jax Notes: Malocculusion in the laboratory mouse, www.jax.org/jaxmice
21. Mercenier A, Pavan S, Pot B: Probiotics as biotherapeutic agents: Present knowledge and future prospects. Curr Pharm Design 8:99-110, 2002
22. Tomasik PJ, Tomasik P: Probiotics and prebiotics: Review. Cereal Chem 80:113-117, 2003
23. Kocian J: Lactobacilli in the treatment of dyspepsia in dysmicrobia of various aetiology. Vnitrni Lekarstvi 40:79-83, 1994
24. Bielanski W, Ziemniak W, Plonka M, Dobrzanska MJ, Kaminska A, Konturek SJ: Improvement of anti-Helicobacter pylori therapy by the use of commercially available probiotics. Gut 51(11):A98, 2002
25. Hamilton-Miller JMT: The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrobial Agents 22:360-366, 2003
26. Brzozowski T, Konturek P.C, Bielanski W, Kwiecien S, Drozdowicz D, Pajdo R, Konturek SJ: Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression and functional impairment in Helicobacter pylori (HP)-infected Mongolian gerbils. Annual AGA-DDW meeting, Orlando, FL, 2003, abstr M1501
27. Fernandez MF, Boris S, Barbes C: Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J Appl Microbiol 94(3):449-455, 2003
28. Saito N, Lpmosjo L, Sato F, Kato M, Takeda H, Sagiyama T, Asaka M: Plural transformation-processes from spiral to coccoid Helicobacter pylori and its viability. J Infect 46(1):49-55, 2003
29. Stingl K, Uhlemann EM, Deckers-Hebestreit G, Schmid R, Bakker EP, Altendorf K: Prolonged survival and cytoplasmic pH homeostasis of Helicobacter pylori at pH1. Infect Immun 69:1178-11180, 2001
30. Sachs G, Weeks DL, Melchers K, Scott DR: The gastric biology of Helicobacter pylori. Annu Rev Phisiol 65:349-369, 2003
31. Sgouras D, Maragkoudakis P, Petraki D, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A: In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microb 70:518-526, 2004
32. Mangell P, Nejdfors P, Wang M, Ahrne S, Westrom B, Thorlacius H, Jeppsson B: Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig Dis Sci 47(3):511-516, 2002
33. Fried LF, Palevsky PM: Renal disease. Med Clin No Am 81(3):585-609, 1997
34. De Waard R, Snel J, Bokken GC, Tan PS, Schut F, Huis In't Veld JH: Comparison of faecal Lactobacillus populations in experimental animals from different breeding facilities and possible consequences for probiotic studies. Left Appl Microbiol 34(2):105-109, 2002
35. Dieleman L, Goerres M, Arends A, Sprengers D, Torrice C, Hoentjen F, Grenther WB, et al.: Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52(3):370-376, 2003
36. Yuki N, Shimazaki T, Kushiro A, Watanabe K, Uchida K, Yuyama T, Morotomi M: Colonization of the stratified squamous epithelium of the nonsecreting area of the horse stomach by lactobacilli. Appl Environ Microbiol 66(11):5030-5034, 2000
37. Wu JJ, Lo CY, Wu HW, Chen JH, Lin YS, Lin MD: Impact of supplement with Lactobacillus and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 16:1669-1675, 2002
38. Isolauri E: Probiotics for infectious diarrheoea. Gut 52:436-437, 2003
39. Bezkorovainy A: Probiotics: Determinants of survival and growth in the gut. Am J Clin Nutr 73:399S-405S, 2001
40. Resta-Lenert S, Barrett K: Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52:988-997, 2003
41. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA: Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276;G941-G950, 1999
42. Johnson-Henry K, Tompkins TA, Sherman PM: Lactobacillus species inhibit adherence of enteropathogenic Escherichia coli and enterohemorrhagic E. coli to host epithelial cells. Annual meeting of the Danone Symposium on Fermented Food, Fermentation and Intestinal Flora, New York, 2000, abstr 7
43. Sutton P, Wilson J, Lee A: Further development of Helicobacter pylori mouse vaccination model. Vaccine 18:2677-2685, 2000
44. Garhart CA, Redline RW, Nedrud JG, Czinn SJ: Clearance of Helicobacter pylori infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice. Infect Immun 70:3529-3538, 2002